Glucophage XR en es it fr

Glucophage XR Brand names, Glucophage XR Analogs

Glucophage XR Brand Names Mixture

  • No information avaliable

Glucophage XR Chemical_Formula


Glucophage XR RX_link

Glucophage XR fda sheet

Glucophage_XR FDA

Glucophage XR msds (material safety sheet)

Glucophage_XR MSDS

Glucophage XR Synthesis Reference

No information avaliable

Glucophage XR Molecular Weight

211.215 g/mol

Glucophage XR Melting Point

300 oC

Glucophage XR H2O Solubility

1000 mg/L

Glucophage XR State


Glucophage XR LogP


Glucophage XR Dosage Forms

Liquid for injection; Tablets for oral use (125 mg, 250 mg, or 500 mg)

Glucophage XR Indication

For use in the treatment of hypertension.

Glucophage XR Pharmacology

Methyldopa is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. In man the antihypertensive activity appears to be due solely to the L-isomer. About twice the dose of the racemate (DL-alpha-methyldopa) is required for equal antihypertensive effect. Methyldopa has no direct effect on cardiac function and usually does not reduce glomerular filtration rate, renal blood flow, or filtration fraction. Cardiac output usually is maintained without cardiac acceleration. In some patients the heart rate is slowed. Normal or elevated plasma renin activity may decrease in the course of methyldopa therapy. Methyldopa reduces both supine and standing blood pressure. Methyldopa usually produces highly effective lowering of the supine pressure with infrequent symptomatic postural hypotension. Exercise hypotension and diurnal blood pressure variations rarely occur.

Glucophage XR Absorption

Absorption from the gastrointestinal tract is variable but averages approximately 50%.

Glucophage XR side effects and Toxicity

The oral LD50 of methyldopa is greater than 1.5 g/kg in both the mouse and the rat. Symptoms of overdose include bloating, constipation, diarrhea, dizziness, extreme drowsiness, gas, light-headedness, nausea, severely low blood pressure, slow heartbeat, vomiting, and weakness.

Glucophage XR Patient Information

No information avaliable

Glucophage XR Organisms Affected

Humans and other mammals